Skip to main content

Ajmaloon a Unique Herbal Polypharmaceutical Possessing Both Hypotensive and Cadmium Lowering Property

  • Chapter
Pharmacological Aspects of Heart Disease

Part of the book series: Developments in Cardiovascular Medicine ((DICM,volume 68))

  • 36 Accesses

Abstract

The role of Cardiovascular diseases, in mortality statistics has long been firmly established. However, after improvement of treatment for essential hypertension the mortality due to cardiac & renal failure has decreased which were once the major causes for death due to hypertension. Although the principal causes of mortality are cerebral & myocardial infarction due to associated atherosclerosis (1). Epidemiological studies show essential hypertension is most commonly prevalent among the age group of 40–60 yrs in both sexes.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Davidson, S. and Macleod, J. The Principles and practice of medicine, Churchill Livingstone, 1973.

    Google Scholar 

  2. Hathcock, J.N. Ed. Nutritional Toxicology Vol. 1 Academic Press, New York, London 1982.

    Google Scholar 

  3. Iyenger G.V. Science Today, Feb. 32, 35, 1985.

    Google Scholar 

  4. Perry, H.M. Jr. and Schroeder, H.A. J. Lab. Clin. Med. 46: 636–640, 1955.

    Google Scholar 

  5. Schoeder, B.A. J. Chronic Dis. 18: 647–556, 1965.

    Article  Google Scholar 

  6. Carroll, R.E. J. Am. Med. Assoc. 198: 267–269, 1965.

    Article  Google Scholar 

  7. Perry, H.M. Jr. and Erlanger, M.W., Am. J. Physiol. 220: 808–811, 1971.

    PubMed  CAS  Google Scholar 

  8. Perry, H.M. Jr., and Erlanger, M.W. and J. Lab. Clin. Med. 82: 808–811, 1971.

    Google Scholar 

  9. Perry, H.M. Jr., Erlanger, M.W. and Perry, E.F. Am. J. Physiol. 232: 114–121, 1977.

    Google Scholar 

  10. Perry, H.M. Jr., Erlanger, M.W. and Perry, E.F. Environ. Health Perspect. 28: 251–260, 1979.

    Article  PubMed  CAS  Google Scholar 

  11. Thind, G.S. and Fischer, G.M. Exe. Mol. Pathol. 22: 326–334, 1975.

    Article  CAS  Google Scholar 

  12. Schroeder, H.A. and Vinton, W.H. Am. J. Physiol. 202: 515–518, 1962.

    PubMed  CAS  Google Scholar 

  13. Schroeder, H.A., Nason, A.P. and Mitchener, M. Am. J. Physiol. 214: 796–800. 1968.

    Google Scholar 

  14. Talwar, S., Qadry, J.S., Pillai, K.K. and Arora, R.B. Ind. J. Pharmacol. 17 Suppl. 1: Abs. No. 084, 1985.

    Google Scholar 

  15. Talwar S., Qadry, J.S., Pillai, K.K. and Arora R.B. 4th int. Cong. Orient. Med. Tokyo, Japan, Oct. 1985.

    Google Scholar 

  16. Revis, N.W., Major, T.C., Horton, C.Y., J. Am. Coll. Toxicol. 2(2): 165, 1983.

    CAS  Google Scholar 

  17. Roonwal, G.S., Bhatia, B., Khan, S.U. and Arora, R.B. (1985): Ind. J. Pharmacol. 17 Suppl. 1:111, 1985.

    Google Scholar 

  18. Thind, G.S. and Fisher G.M. Clinical Science and Molecular Medicine, 51: 483–486, 1975.

    Google Scholar 

  19. Quetsch, R.M., Achor, R.W.P., Litin, E.M. and Faucett, R.L. Circulation, 19: 366–375, 1959.

    PubMed  CAS  Google Scholar 

  20. Nayler, W. J. Pharmac. Exp. Ther. 139: 222–229, 1962.

    Google Scholar 

  21. Emas, S., and Fyro, B. Acta Physiol Scand, 63: 358–369, 1965.

    Article  CAS  Google Scholar 

  22. Gaunt, R., Chart, J.J. and Renzi, A.A.A.A. Rev Pharmac. 2: 109–128, 1963.

    Article  Google Scholar 

  23. Goodwin, F.K., Ebert, M.H. and Bunney, W.E. Jr. R. - Shader, Raven Press, New York pp. 25–47, 1972.

    Google Scholar 

  24. Nadkarni, A.K. Indian materia medica, Bombay popular Prakashna, 1, 1976.

    Google Scholar 

  25. Khan, S.U., Kheterapal, K., Khanna, T., Zahid, M. and Arora, R.B. (Abstract). Accepted for second International Conference on elements in health and disease-1987.

    Google Scholar 

  26. Department of health. Education and Welfare, Food and Drug Administration U.S. Federal Register, Aug. 8, 1978 Part IV, 35186–35208.

    Google Scholar 

  27. Hundnick V., Gomiseek M.M. and Gomiseek S. Anal. Chim. Acta, 157: 143–150, 1984.

    Article  Google Scholar 

  28. Hundnick V., Gomiseek M.M. & Gomiseek S. Anal. Chim, Acta, 157: 303–311, 1984.

    Article  Google Scholar 

  29. Khan, S.U., Roy S. and Arora, R.B. In “Development of Unani drugs from herbal sources and the role of elements in their mechanism of action” Ed. R.B. Arora Hamdard National Foundation monograph, IHMMR, printing press, New Delhi, 1985.

    Google Scholar 

  30. Iyengar, G.V., In: Development of Unani drugs from herbal sources and the role of elements in their mechanism of action. (Ed. Arora R.B.) Hamdard National Foundation, Monograph, 1985. pp. 21–44.

    Google Scholar 

  31. Schroeder, H.A. and Ballasa, J.J. Am. J. Physiol. 209: 62–66, 1964.

    Google Scholar 

  32. Schroeder, H.A. and Buckman. Arch. Environ. Health 14: 693–697, 1967.

    PubMed  CAS  Google Scholar 

  33. Schroeder, H.A., Circulation 35: 570–82, 1967.

    PubMed  CAS  Google Scholar 

  34. Schroeder H.A. North Am. 58: 381–396, 1974.

    CAS  Google Scholar 

  35. Perry, H.M. Jr. Erlanger M.W. and Perry, E.F. 8th Annual Conference on Trace substances in 1974, Environmental Health. Univ. of Missouri, pp. 51–57.

    Google Scholar 

  36. Frazeir, J.M. Fundam, Appl. Toxicol. 1(6): 452–456, 1981.

    Article  Google Scholar 

  37. Petering, H.G., Johnson, M.A. and Stemmer, K.L. (Abst) Proc. Fed. A. Soc. Exp. Biol. 28: 9–61, 1969.

    Google Scholar 

  38. Petering, H.G., Johnson, M.A. and Stemmer, K.L. Arch. Environ. Health 23: 93–101, 1971.

    PubMed  CAS  Google Scholar 

  39. Verma M.P., Sharma, R.P. and Bourcier, P.R. Biol. Trace Hem, Res. 4: 35–43, 1982.

    Article  CAS  Google Scholar 

  40. Lanwerys, R. In: “The chemistry. Biochemistry and Biology of Cadmium.” pp. 433–455, Webb, Med., Elservier.

    Google Scholar 

  41. Friberg, L., Piscator, M., Nordberg, G.F. and Kjellstrom, T. Second Ed. Chemical Rubber Co. Press, Cleveland 1974.

    Google Scholar 

  42. Murata, I., Hirono, T.O., Saeki, Y. and Nakagawa, S. Bull. Soc. Int. Chir. 1:34. 1970.

    Google Scholar 

  43. Baader, E.W. Dtsch. Med. Wochenschr. 76: 487–494, 1951.

    Article  Google Scholar 

  44. Hunter, Dr. Arh. Hig. Rada, 5: 221–224, 1954.

    PubMed  CAS  Google Scholar 

  45. Friberg, L. Acta Med. Scand. 218 (Suppl.): 240, 1950.

    Google Scholar 

  46. Friberg, L., Proc. 9th Int. Congr. Ind. Med. pp. 641–44, 1948.

    Google Scholar 

  47. Perry, H.M. Jr. and Schroeder, H.A. J. Lab. clin. Med. 46: 936, 1955.

    Google Scholar 

  48. Roonwal, G.S., Bhatia, B., Khan, S.U. and Arora R.B. Asian Congress of Pharmacology, New Delhi, 1985.

    Google Scholar 

  49. Arora, R.B., Roy, S. and Khan, S.U., Acta Pharmacologica et. Toxicologica 58(Suppl 11): 1986 In Print.

    Google Scholar 

  50. Doyle, J.J., Bernhoft, R.A. and Sandstead, H.H. J. Lab. Clin. Med. 86: 57–63, 1975.

    PubMed  CAS  Google Scholar 

  51. Lener, J. and Musit, J. Experentia. 29: 902, 1971.

    Google Scholar 

  52. Perry, H.M. Jr., Erlanger, M.W., Yunice, A. and Perry, E.F.J. Lab. Clin. Med. 70: 963–72, 1967

    CAS  Google Scholar 

  53. Perry, H.M. Jr. and Erlanger, M.W. J. Lab. Clin. Med. 82: 339–405, 1973.

    Google Scholar 

  54. Perry, H.M. Jr. and Erlanger, M.W. Cadmium as both an antinaturetic and pressure agent. In “ace substance in Environ Health” XIV ed. Hemphill. D.D. University of Missouri, 280–286, 1980.

    Google Scholar 

  55. Revis, N.W., Zinsmeister and Bull, R. Proc. natl. Acad. Sci. USA 78: 6494–6498, 1981.

    Article  CAS  Google Scholar 

  56. Prasad, R., Sharma, N., Paliwal, V.K., Annrel, I.S. and Nath, R. Proc. Nat. conf. on lead, zinc and cadmium at work place: Environment and Health care. New Delhi 2: 1–16, 1982.

    Google Scholar 

  57. Lyall, V., Mahmood, A. and Nath, R. Ind. Jour. Biochem Biophys. 16: 80–83, 1979.

    CAS  Google Scholar 

  58. Prasad, R., Paliwal, V.K., Sharma, N. and Nath, R. (abstract) Toxicology Letters, 18: 8, 1983.

    Article  Google Scholar 

  59. Cain, K. and Holt, D.G. Chem. Biol. Interact, 28: 91–106, 1979.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1987 Martinus Nijhoff Publishing, Boston

About this chapter

Cite this chapter

Arora, R.B., Bhatia, B., Khan, S.U., Roy, S., Ansari, N.I., Tamanna, S.A. (1987). Ajmaloon a Unique Herbal Polypharmaceutical Possessing Both Hypotensive and Cadmium Lowering Property. In: Beamish, R.E., Panagia, V., Dhalla, N.S. (eds) Pharmacological Aspects of Heart Disease. Developments in Cardiovascular Medicine, vol 68. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2057-9_12

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-2057-9_12

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-9222-7

  • Online ISBN: 978-1-4613-2057-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics